The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management: a narrative review focusing on principal risk modifiers-Reference-Cited by-同舟云学术

The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management: a narrative review focusing on principal risk modifiers

Published:2023-09-28 Issue:10 Volume:16 Page:891-911
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Lonardo Amedeo¹^ORCID

Affiliation:

1. Operating Unit of Metabolic Syndrome, Azienda Ospedaliero-Unversitaria di Modena, Ospedale Civile di Baggiovara, Baggiovara, Modena, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2023.2259306

Reference215 articles.

1. History of Nonalcoholic Fatty Liver Disease

2. Clinical Management of Metabolic Syndrome

3. The metabolic syndrome—a new worldwide definition

4. Harmonizing the Metabolic Syndrome

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Depression and the risk of non-alcohol fatty liver disease: Results from a cross-sectional study and a Mendelian randomization analysis;Journal of Affective Disorders;2024-12

2. Gut microbes, diet, and genetics as drivers of metabolic liver disease: a narrative review outlining implications for precision medicine;The Journal of Nutritional Biochemistry;2024-11

3. Global Prevalence of Nonalcoholic Fatty Liver Disease: An Updated Review Meta-Analysis comprising a Population of 78 million from 38 Countries;Archives of Medical Research;2024-09

4. Childhood maltreatment and risk of metabolic dysfunction-associated steatotic liver disease – Evidence of sex-specific associations in the general population;Journal of Psychosomatic Research;2024-08

5. Alanine aminotransferase predicts incident steatotic liver disease of metabolic etiology: Long life to the old biomarker!;World Journal of Gastroenterology;2024-06-28